‘Serum’s pneumococcal vaccine will be available by June 2020’
Serum Institute is optimistic that its pneumococcal vaccine will be available in India by June 2020. The vaccine is yet to be approved by the DCGI. But phase-3 trial data…
Category: Pharmaceutical companies
WHO prequalifies Serum’s low-cost pneumococcal vaccine
WHO has prequalified Pune-based Serum Institute’s pneumococcal conjugate vaccine made of 10 serotypes that are widely prevalent and cause pneumonia in Latin America, Africa and Asia. The vaccine will cost…
Bharat Biotech’s typhoid conjugate vaccine offers 82% protection
Bharat Biotech’s typhoid conjugate vaccine shows nearly 82% efficacy at 12 months in a Phase-3 trail carried out in Nepal. It can be be given to babies as young as…
Merck’s unlicensed Ebola vaccine shows 97.5% efficacy in Congo
Merck’s Ebola vaccine, which underwent phase-3 trial during the 2014-2015 Ebola epidemic in west Africa, has shown 97.5% efficacy in preventing Ebola disease when used during the current epidemic in…
Jamia researchers develop ultrasensitive quantum thermometer
Jamia Millia Islamia researchers have developed a highly sensitive quantum thermometer using graphene quantum dots. The thermometer can measure micro Kelvin changes in temperature, and has a quick response time…
In a first, WHO recommends quadrivalent influenza vaccine
Sanofi has launched in India its quadrivalent influenza vaccine (FluQuadri) containing two A virus strains — H1N1 and H3N2 — and two B virus strians — Victoria and Yamagata — for active…
Growing interest in HPV vaccination in India
Delhi and Punjab have introduced HPV vaccination and are expanding it, while a few States have shown interest. And the National Technical Advisory Group on Immunisation is considering the introduction…
Serum’s rotavirus vaccine is safe and efficacious
In Phase III trial, Serum Institute’s rotavirus vaccine (ROTASIIL) was found to have nearly 55% efficacy against the very severe form of rotavirus diarrhoea and nearly 39% efficacy in severe…
